The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...
Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.
Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...
The Motley Fool on MSN3d
Is It Time to Sell Eli Lilly and Pfizer Stocks?Lilly and Pfizer stocks have sold off sharply in recent weeks. Both drugmakers have had some bad news that caused their ...
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...
No financial details of the collaborations were released. However, Pfizer and Flagship committed $50 million each for the ...
Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend ...
Chris Boshoff will take over as Pfizer’s next chief scientific officer as of January 1, replacing Mikael Dolsten who led the ...
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...
Zai Lab and Pfizer Inc. are teaming up in China to fight the deadly carbapenem-resistant Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback